Our study found that EF treatment significantly reduced the ratio of phosphorylated-p65/p65 in both in vitro and in vivo studies, suggesting an inhibitory effect of NF-κB pathway might be involved in the therapeutic effect of EF on ischemic stroke. Here, NFKB1 is linked to ischemic stroke.